The Dutch Life Sciences conference in Leiden is dedicated to accelerating change in healthcare. Antleron and its partner Quality by Design (QbD) organized a morning session on topic of ATMPs.
The ‘Advanced breakthrough therapies, from idea to patient!’ session featured the following speakers:
Bart van Acker, Founder/Managing Director Quality by Design (QbD)
Jan Schrooten, Co-Founder & CEO Antleron
Ingrid Maes, Managing Director & Co-founder Inovigate
Hans de Munter, CEO Neuroplast
Jan Schrooten presenting at the Dutch Life Sciences conference.
More info on the DLSC conference: https://www.dutchlifesciences.com/programme